JESSICA JOHNSON: Open Payments
NPI 1194020511 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$720 in 36 payments from 13 companies in 2025. Trend: 2023 $388 · 2024 $286 · 2025 $720
Food & beverage: $720
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $173 |
| GlaxoSmithKline, LLC. | 6 | $107 |
| Astellas Pharma US Inc | 3 | $98 |
| AstraZeneca Pharmaceuticals LP | 5 | $76 |
| Exact Sciences Corporation | 3 | $61 |
| Teva Pharmaceuticals USA, Inc. | 3 | $54 |
| Amgen Inc. | 1 | $28 |
| Lilly USA, LLC | 1 | $26 |
| Bausch Health US, LLC | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
Products named: TRELEGY ELLIPTA, Veozah, Cologuard Collection Kit, AIRSUPRA, AUSTEDO XR, Wegovy, Rybelsus, Ozempic.
Industry payments across PA — which companies pay providers there.
